A Development Plan of in Vitro Diagnostics of Immuno Magnetic Reduction Assay - A Rapid Etection Kit of Enterobacteraceae in Blood or Blood Culture

This study has been completed.
Sponsor:
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01255098
First received: December 3, 2010
Last updated: NA
Last verified: December 2010
History: No changes posted
  Purpose

This plan is to develop blood culture or to measure diagnostics of Immuno Magnetic Reduction assay in the first stage.


Condition
Immuno Magnetic Reduction

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: A Development Plan of in Vitro Diagnostics of Immuno Magnetic Reduction Assay - A Rapid Etection Kit of Enterobacteraceae in Blood or Blood Culture

Further study details as provided by Taipei Medical University WanFang Hospital:

Enrollment: 300
Study Start Date: November 2009
Study Completion Date: November 2010
Groups/Cohorts
Experimental Group
Control Group

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

emergency cases

Criteria

Inclusion Criteria:

  • emergency cases
  • blood culture of positive and negative cases which storage in 4℃ every day

Exclusion Criteria:

  • not emergency cases of blood culture
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01255098

Locations
Taiwan
Taipei Medical University WanFang Hospital
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
Principal Investigator: Giueng-Chueng Wang Taipei Medical University WanFang Hospital
  More Information

No publications provided

Responsible Party: Giueng-Chueng Wang, Laboratory Medicine
ClinicalTrials.gov Identifier: NCT01255098     History of Changes
Other Study ID Numbers: 98085
Study First Received: December 3, 2010
Last Updated: December 3, 2010
Health Authority: Taiwan: Department of Health

ClinicalTrials.gov processed this record on April 17, 2014